Back to Journals » Biologics: Targets and Therapy » Volume 9

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

Total article views   HTML views PDF downloads Totals
10,355 Dovepress* 9,921+ 1,747 11,668
PubMed Central* 434 143 577
Totals 10,355 1,890 12,245
*Since 19 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar